Evolent Health, Inc. (EVH)

USD 10.69

(7.44%)

Operating Income Summary of Evolent Health, Inc.

  • Evolent Health, Inc.'s latest annual operating income in 2023 was -71.21 Million USD , down -19.01% from previous year.
  • Evolent Health, Inc.'s latest quarterly operating income in 2024 Q1 was 5.82 Million USD , up 127.3% from previous quarter.
  • Evolent Health, Inc. reported an annual operating income of -59.83 Million USD in 2022, down -297.81% from previous year.
  • Evolent Health, Inc. reported an annual operating income of 30.24 Million USD in 2021, up 179.85% from previous year.
  • Evolent Health, Inc. reported a quarterly operating income of 5.82 Million USD for 2024 Q1, up 127.3% from previous quarter.
  • Evolent Health, Inc. reported a quarterly operating income of -21.56 Million USD for 2023 Q2, down -1107.61% from previous quarter.

Annual Operating Income Chart of Evolent Health, Inc. (2023 - 2012)

Historical Annual Operating Income of Evolent Health, Inc. (2023 - 2012)

Year Operating Income Operating Income Growth
2023 -71.21 Million USD -19.01%
2022 -59.83 Million USD -297.81%
2021 30.24 Million USD 179.85%
2020 -37.88 Million USD 68.54%
2019 -120.4 Million USD -153.6%
2018 -47.48 Million USD 34.82%
2017 -72.84 Million USD 69.32%
2016 -237.41 Million USD -452.5%
2015 -42.97 Million USD -70.21%
2014 -25.24 Million USD -19.34%
2013 -21.15 Million USD -7.83%
2012 -19.61 Million USD 0.0%

Peer Operating Income Comparison of Evolent Health, Inc.

Name Operating Income Operating Income Difference
American Well Corporation -692.14 Million USD 89.712%
Doximity, Inc. 163.87 Million USD 143.454%
MultiPlan Corporation 173.4 Million USD 141.067%
Phreesia, Inc. -131.77 Million USD 45.959%
Teladoc Health, Inc. -248.55 Million USD 71.35%
Veeva Systems Inc. 429.33 Million USD 116.586%